Header Logo

Connection

Doris Benbrook to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Doris Benbrook has written about Drug Evaluation, Preclinical.
Doris Benbrook
Connection Strength
0.083
Drug Evaluation, Preclinical
  1. Cyclin D1 degradation is sufficient to induce G1 cell cycle arrest despite constitutive expression of cyclin E2 in ovarian cancer cells. Cancer Res. 2009 Aug 15; 69(16):6565-72.
    View in: PubMed
    Score: 0.083
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.